These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12091363

  • 1. Novel "hybrid" iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells.
    Lovejoy DB, Richardson DR.
    Blood; 2002 Jul 15; 100(2):666-76. PubMed ID: 12091363
    [Abstract] [Full Text] [Related]

  • 2. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR, Milnes K.
    Blood; 1997 Apr 15; 89(8):3025-38. PubMed ID: 9108424
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR, Tran EH, Ponka P.
    Blood; 1995 Dec 01; 86(11):4295-306. PubMed ID: 7492790
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues.
    Kalinowski DS, Sharpe PC, Bernhardt PV, Richardson DR.
    J Med Chem; 2007 Nov 29; 50(24):6212-25. PubMed ID: 17963372
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites.
    Walcourt A, Loyevsky M, Lovejoy DB, Gordeuk VR, Richardson DR.
    Int J Biochem Cell Biol; 2004 Mar 29; 36(3):401-7. PubMed ID: 14687919
    [Abstract] [Full Text] [Related]

  • 10. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB, Lovejoy DB, Watts RN, Richardson DR.
    Clin Cancer Res; 2003 Jan 29; 9(1):402-14. PubMed ID: 12538494
    [Abstract] [Full Text] [Related]

  • 11. Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment.
    Yuan J, Lovejoy DB, Richardson DR.
    Blood; 2004 Sep 01; 104(5):1450-8. PubMed ID: 15150082
    [Abstract] [Full Text] [Related]

  • 12. Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool.
    Walcourt A, Kurantsin-Mills J, Kwagyan J, Adenuga BB, Kalinowski DS, Lovejoy DB, Lane DJ, Richardson DR.
    J Inorg Biochem; 2013 Dec 01; 129():43-51. PubMed ID: 24028863
    [Abstract] [Full Text] [Related]

  • 13. Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
    Opletalová V, Kalinowski DS, Vejsová M, Kunes J, Pour M, Jampílek J, Buchta V, Richardson DR.
    Chem Res Toxicol; 2008 Sep 01; 21(9):1878-89. PubMed ID: 18698850
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.
    Kalinowski DS, Sharpe PC, Bernhardt PV, Richardson DR.
    J Med Chem; 2008 Jan 24; 51(2):331-44. PubMed ID: 18159922
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy.
    Serda M, Kalinowski DS, Mrozek-Wilczkiewicz A, Musiol R, Szurko A, Ratuszna A, Pantarat N, Kovacevic Z, Merlot AM, Richardson DR, Polanski J.
    Bioorg Med Chem Lett; 2012 Sep 01; 22(17):5527-31. PubMed ID: 22858101
    [Abstract] [Full Text] [Related]

  • 19. Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
    Potuckova E, Jansova H, Machacek M, Vavrova A, Haskova P, Tichotova L, Richardson V, Kalinowski DS, Richardson DR, Simunek T.
    PLoS One; 2014 Sep 01; 9(2):e88754. PubMed ID: 24586383
    [Abstract] [Full Text] [Related]

  • 20. Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.
    Richardson DR, Sharpe PC, Lovejoy DB, Senaratne D, Kalinowski DS, Islam M, Bernhardt PV.
    J Med Chem; 2006 Nov 02; 49(22):6510-21. PubMed ID: 17064069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.